Keyphrases
Breast
100%
Targeted Therapy
100%
Human Epidermal Growth Factor Receptor 2 (HER2)
100%
HER2-positive
100%
Overall Survival
50%
Systemic Therapy
25%
Ongoing Clinical Trials
25%
Multivariable
25%
Adjuvant Therapy
12%
5-year Survival
12%
Hormonal Therapy
12%
Inclusion Criteria
12%
Prognostic Factors
12%
Survival Benefit
12%
Multivariable Logistic Regression
12%
Biopsy-proven
12%
Invasive Breast Cancer
12%
Comorbidity Scores
12%
Group-based
12%
Ductal Carcinoma in Situ
12%
Survival Outcomes
12%
National Cancer Database
12%
Kaplan-Meier Analysis
12%
Cox Proportional Hazards Modeling
12%
Direct Therapy
12%
Charlson
12%
Medicine and Dentistry
Targeted Therapy
100%
Intraductal Carcinoma
100%
Overall Survival
83%
Dichlorisoprenaline
83%
Clinical Trial
33%
Systemic Therapy
33%
Malignant Neoplasm
16%
Base
16%
Adjuvant Therapy
16%
Hormone Therapy
16%
Prognostic Factor
16%
Kaplan Meier Method
16%
Biopsy Technique
16%
Logistic Regression Analysis
16%
Predictive Factor
16%
HER2-Positive Breast Cancer
16%
Comorbidity
16%